Free Float 53,92 %
Shares Float 58,52 M
Shares Outstanding 108,52 M
PHARMACOLOG I UPPSALA B
Share · SE0019071812 · A3DWNW (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PHARMACOLOG I UPPSALA B
No Price
Share Float & Liquidity
Company Profile for PHARMACOLOG I UPPSALA B Share
Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company was founded in 2007 and is based in Uppsala, Sweden.
Company Data
Name PHARMACOLOG I UPPSALA B
Company Pharmacolog i Uppsala AB (publ)
Website
https://www.pharmacolog.com
Primary Exchange 
Frankfurt
Frankfurt
WKN A3DWNW
ISIN SE0019071812
Asset Class Share
Sector Healthcare
Industry Medical - Devices
CEO Lars Gusch
Market Capitalization 11 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address Ekeby bruk 2H, 752 63 Uppsala
IPO Date 2015-06-08
Dividends from 'PHARMACOLOG I UPPSALA B'
| Ex-Date | Dividend per Share |
|---|---|
| 16.04.2021 | 3,50 SEK |
Stock Splits
| Date | Split |
|---|---|
| 20.06.2023 | 627:500 |
| 16.05.2019 | 27:25 |
| 04.05.2018 | 1:2 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | PHLOG-B.ST |
| Frankfurt | P750.F |
More Shares
Investors who hold PHARMACOLOG I UPPSALA B also have the following shares in their portfolio:
